STOCK TITAN

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Penumbra (NYSE: PEN) has announced its participation in the 43rd Annual J.P.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Penumbra (NYSE: PEN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team will deliver a presentation on Monday, January 13, 2025, at 6:00pm ET/3:00pm PT.

Investors and interested parties can access a webcast of the presentation through the 'Events and Presentations' section under the 'Investors' tab on Penumbra's website. The presentation recording will remain available for a minimum of two weeks following the event.

Loading...
Loading translation...
Argus Session date unavailable
-0.29% session move Open Argus
Details

News Market Reaction – PEN

The recorded move for PEN in the trading session of this news was -0.29%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ALAMEDA, Calif., Dec. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025.

Event:     43rd Annual J.P. Morgan Healthcare Conference
Date:       Monday, January 13, 2025
Time:      6:00pm ET/3:00pm PT

A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com.  The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra 
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations
Penumbra, Inc.
investors@penumbrainc.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302337761.html

SOURCE Penumbra, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Penumbra (PEN) presenting at the 2025 J.P. Morgan Healthcare Conference?

Penumbra is scheduled to present at the conference on Monday, January 13, 2025, at 6:00pm ET/3:00pm PT.

How can investors watch Penumbra's (PEN) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation via webcast on Penumbra's website under the 'Events and Presentations' section of the 'Investors' tab at www.penumbrainc.com.

How long will Penumbra's (PEN) 2025 J.P. Morgan Conference presentation be available online?

The webcast will be available on Penumbra's website for at least two weeks following the event.

Which Penumbra (PEN) executives will be presenting at the 2025 J.P. Morgan Healthcare Conference?

The press release indicates that the management team will be presenting, but does not specify which executives will participate.

Keep reading